pentoxifylline has been researched along with Mood Disorders in 1 studies
Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline (PTX) is a phosphodiesterase inhibitor with potent anti-inflammatory and antioxidant effects, with additional pleiotropic effects that lead to improved CBF and increases in brain derived neurotrophic factor (BDNF) levels." | 6.72 | Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment. ( Gill, H; Goldstein, BI; Ho, R; Lee, Y; Lipsitz, O; Lui, LMW; Majeed, A; Mansur, RB; McIntyre, RS; Nasri, F; Phan, L; Rashidian, H; Rodrigues, N; Rosenblat, JD; Siegel, AN; Subramaniapillai, M; Toma, S; Wilkialis, L, 2021) |
| "Pentoxifylline (PTX) is a phosphodiesterase inhibitor with potent anti-inflammatory and antioxidant effects, with additional pleiotropic effects that lead to improved CBF and increases in brain derived neurotrophic factor (BDNF) levels." | 2.72 | Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment. ( Gill, H; Goldstein, BI; Ho, R; Lee, Y; Lipsitz, O; Lui, LMW; Majeed, A; Mansur, RB; McIntyre, RS; Nasri, F; Phan, L; Rashidian, H; Rodrigues, N; Rosenblat, JD; Siegel, AN; Subramaniapillai, M; Toma, S; Wilkialis, L, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siegel, AN | 1 |
| Rodrigues, N | 1 |
| Nasri, F | 1 |
| Wilkialis, L | 1 |
| Lipsitz, O | 1 |
| Lee, Y | 1 |
| Gill, H | 1 |
| Subramaniapillai, M | 1 |
| Phan, L | 1 |
| Majeed, A | 1 |
| Lui, LMW | 1 |
| Rashidian, H | 1 |
| Ho, R | 1 |
| Toma, S | 1 |
| Goldstein, BI | 1 |
| Mansur, RB | 1 |
| McIntyre, RS | 1 |
| Rosenblat, JD | 1 |
1 review available for pentoxifylline and Mood Disorders
| Article | Year |
|---|---|
Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment.
Topics: Animals; Antidepressive Agents; Antimanic Agents; Drug Delivery Systems; Free Radical Scavengers; Hu | 2021 |